Imatinib and haemoglobin decreased Patient Reports February 11, 2012

Imatinib Side Effects Report #4591312-X
Imatinib side effect was reported by a Health Professional from on Feb 18, 2005. Male patient, 67 years of age, was diagnosed with myeloproliferative disorder and was treated with Imatinib. After drug was administered, patient experienced the following side effects: biopsy bone marrow abnormal, blast cell crisis, chills, chromosome analysis abnormal, haemoglobin decreased, neutropenia, night sweats, pleural effusion. Imatinib dosage: 100 MG/DAY. Patient died.

Imatinib Side Effects Report #5208938-2
Imatinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 11, 2007. Female patient, 51 years of age, was diagnosed with glioblastoma multiforme and was treated with Imatinib. After drug was administered, patient experienced the following side effects: haemoglobin decreased, headache , leukopenia, nausea , neutropenia, treatment noncompliance. Imatinib dosage: 500MG BID. During the same period patient was treated with HYDROXYUREA, DEXAMETHASONE, DILANTIN, ZYRTEC, NEXIUM. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #4673154-X
Imatinib side effect was reported by a Health Professional from on May 23, 2005. Male patient, weighting 175.7 lb, was diagnosed with glioblastoma multiforme and was treated with Imatinib. After drug was administered, patient experienced the following side effects: haemoglobin decreased. Imatinib dosage: 400MG PO BID X 8 DAYS. During the same period patient was treated with TEMOZOLOMIDE, DECADRON, NEXIUM, ZOLOFT, SEROQUEL. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #4763753-9
Imatinib side effect was reported by a Consumer or non-health professional from AUSTRALIA on Aug 31, 2005. Female patient, 60 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with Imatinib. After drug was administered, patient experienced the following side effects: abdominal pain upper, anaemia, haemodynamic instability, haemoglobin decreased, ileus paralytic, intra-abdominal haemorrhage, liver function test abnormal, malignant neoplasm progression. Imatinib dosage: 400 MG, BID. Patient was hospitalized. Patient died.


Imatinib Side Effects Report #5375834-X
Imatinib side effect was reported by a Physician from CANADA on June 26, 2007. Male patient, 59 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with Imatinib. After drug was administered, patient experienced the following side effects: anorexia, atrial fibrillation , disease progression, fatigue, haematocrit decreased, haemoglobin decreased, hepatic embolisation, leukopenia. Imatinib dosage: 400 MG, QD. During the same period patient was treated with IMATINIB MESYLATE, IMATINIB MESYLATE, IMATINIB MESYLATE. Patient recovered.

Imatinib Side Effects Report #5385019-9
Imatinib side effect was reported by a Physician from CANADA on July 03, 2007. Male patient, 59 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with Imatinib. After drug was administered, patient experienced the following side effects: anorexia, atrial fibrillation , fatigue, haematocrit decreased, haemoglobin decreased, hepatic embolisation, leukopenia, liver disorder. Imatinib dosage: 400 MG, QD. During the same period patient was treated with IMATINIB MESYLATE, IMATINIB MESYLATE, IMATINIB MESYLATE. Patient recovered.

Imatinib Side Effects Report #5119770-2
Imatinib side effect was reported by a Health Professional from CANADA on Sept 21, 2006. Male patient, 61 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: bone marrow failure, chromosome abnormality, chronic myeloid leukaemia, fatigue, haemoglobin decreased, marrow hyperplasia, neutropenia, pancytopenia. Imatinib dosage: unknown. Patient recovered.

Imatinib Side Effects Report #5874478-0
Imatinib side effect was reported by a Health Professional from JAPAN on May 30, 2008. Male patient, 41 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: chromosome analysis abnormal, haemoglobin decreased, myelodysplastic syndrome, white blood cell count decreased. Imatinib dosage: 600 MG/DAY. During the same period patient was treated with IMATINIB MESYLATE. Patient recovered.

Imatinib Side Effects Report #5235949-3
Imatinib side effect was reported by a Physician from CHINA on Jan 30, 2007. Female patient, 24 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: aplasia pure red cell, bone marrow failure, haemoglobin decreased, myeloid maturation arrest, platelet count decreased, white blood cell count decreased. Imatinib dosage: 400 MG, QD. Patient recovered.


Imatinib Side Effects Report #5669602-9
Imatinib side effect was reported by a Health Professional from TURKEY on Mar 07, 2008. Male patient, 17 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: asthenia, chloroma, cytogenetic analysis abnormal, fatigue, haemoglobin decreased, hepatosplenomegaly, malignant neoplasm progression, mass, oedema. Imatinib dosage: 400 MG/D. Patient died.

Imatinib Side Effects Report #5756052-X
Imatinib side effect was reported by a Health Professional from HONG KONG on May 27, 2008. Female patient, 76 years of age, was diagnosed with chronic lymphocytic leukaemia transformation, chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: biopsy lymph gland abnormal, computerised tomogram abnormal, disease progression, dry skin, haemoglobin decreased, hirsutism, nausea , pancytopenia, porphyria non-acute. Imatinib dosage: 600 MG. During the same period patient was treated with IMATINIB MESYLATE, HYDROXYUREA, INTERFERON. Patient died.

Imatinib Side Effects Report #5213531-1
Imatinib side effect was reported by a Physician from FRANCE on Jan 10, 2007. Female patient, 40 years of age, weighting 105.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematocrit decreased, haemoglobin decreased, mucosal inflammation, oesophagitis, pancytopenia, pharyngitis, platelet count decreased, red blood cell count decreased. Imatinib dosage: 400 MG, QD. During the same period patient was treated with PURINETHOL, METHOTREXATE. Patient was hospitalized. Patient recovered.